Traditional - in Shigella naïve subjects |
Well controlled clean system, potentially increasing reproducibility
Immunologically unprimed
Has potential to be predictive of target populations
|
|
Next-generation - in Shigella exposed subjects |
Closer representation of target population environmental variables
Accounts for population genetics
Accounts for the impact of prior exposure/immunologic priming/ baseline immunity
May help to better define protection/efficacy and true CoP
Cost-benefit
Acceleration of interventions
Capacity building
|
Availability of representative circulating strains as inoculum
Sensitivity of the model to overcome pre-existing and variable immunity, potentially decreasing reproducibility
Low AR, impacting ability to draw meaningful conclusions
Differentiating vaccine efficacy from background immunity
Infrastructure, clinical/ containment
|